Osteogenic sarcoma of the extremity with detectable lung metastases at presentation: Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions

Cancer

Volumn 79, Issue 2, 1997, Pages 245-254

  Bacci, Gaetano ^a   Mercuri, Mario ^a   Briccoli, Antonio ^b   Ferrari, Stefano ^a   Bertoni, Franco ^a   Donati, Davide ^a   Monti, Carlo ^a   Zanoni, Antonio ^a   Forni, Cristiana ^a   Manfrini, Marco ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

limb salvage; lung metastases; metastasectomy; neoadjuvant chemotherapy; osteosarcoma

Indexed keywords

ALKALINE PHOSPHATASE; CISPLATIN; DOXORUBICIN; FOLINATE CALCIUM; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; LIMB AMPUTATION; LIMB SALVAGE; LUNG LOBECTOMY; LUNG METASTASIS; LUNG RESECTION; MALE; OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; METHOTREXATE; OSTEOSARCOMA;

EID: 0031015035     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<245::AID-CNCR7>3.0.CO;2-J     Document Type: Article

References (23)

1. Jaffe N, Frei E, Traggis D, Cassady D, Watts JR, Fuller RM. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 1974;291:994-7.
2. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 1979;43:2163-77.
3. Bacci G, Gherlinzoni F, Picci P, Van Horn J, Jaffe N, Guerra A, et al. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. Eur J Cancer Clin Oncol 1986; 22:1337-44.
4. Meyers PA, Heller G, Healey JH, Huvos A, Lane J, Marcove R, et al. Chemotherapy for non-metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10:5-15.
5. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, et al. Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremities. Results in 144 patients preoperatively treated with high-dose methotrexate (iv) followed by cisplatinum (ia) and adriamycin (iv). Cancer 1993;723227-38.
6. Saeter G, Alvegard TA, Stenwig AE, Stenwig AE, Homstrom T, Solheim OP. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high dose methotrexate: a Scandinavian sarcoma group study. J Clin Oncol 1991;9:1766-75.
7. Winkler K, Beron G, Delling G, Heise U, Kabish H, Purfurts C, et al. Neoadjuvant chemotherapy of osteosarcoma. Results of a randomized cooperative trial (Coss-82) with salvage chemotherapy. J Clin Oncol 1988;6:329-36.
8. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-6.
9. Marina NM, Pratt CB, Rao BN, Ahema SJ, Meyer WH. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 1992; 70:2722-7.
10. Meyers P, Heller G, Healey JH, Huvos A, Applewhite A, Sung M, et al. Osteogenic sarcoma with clinically detectable metastases at initial presentation. J Clin Oncol 1993;11:449-53.
11. Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, et al. Histological evaluation of necrosis in osteosarcoma induced by chemotherapy. Cancer 1985;56:1515-21.
12. Pastorino U, Valente M, Gasparini M, Azzarelli A, Santoro A, Tavecchio L, et al. Median stemectomy and multiple resection for metastatic sarcoma. Eur J Cardiothorac Surg 1990;4:477-81.
13. Beattie EJ, Harvey JC, Marcone R, Martini N. Results of multiple pulmonary resections for metastatic osteogenic sarcoma after two decades. J Surg Oncol 1991;46:154-5.
14. Goorin AM, Delorey MG, Lack EE, Gelber RD, Price K, Cassady JR, et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma. Analysis of 32 patients. J Clin Oncol 1984;2:425-31.
15. Beron G, Euler A, Winkler K. Pulmonary metastases from osteogenic sarcoma: complete resection and effective chemotherapy contributing to improved prognosis. Eur Paediatr Haematol Oncol 1985;2:77-85.
16. Putnam JB, Roth JA, Wesley MN, Johnston MR, Rosenberg SA. Survival following aggressive resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. Ann Thorac Surg 1983;36:516-23.
17. Rosen G, Huvos AG, Mosende C, Beattie EJ, Exelby PR, Caparros B, et al. Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 1978;41:841-9.
18. Snyder CL, Saltzman DA, Ferrel CL, Thompson RC, Leonard AS. A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastectomy. Clin Orthop 1991;270:247-53.
19. Ward WG, Mikaelian K, Dorey F, Mirra JM, Sassoon A, Holmes EC, et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994;12:1849-58.
20. Saeter G, Hoie J, Sterving E, Johansson AK, Hannisdal E, Solheim P. Systemic relapse of patients with osteogenic sarcoma. Cancer 1995;93:1084-93.
21. Tabone MD, Kalifa C, Rodary C, Raquin M, Valteau-Couuanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol 1994;12:2614-20.
22. Spremulli EN, Dexter DL. Human tumor cell heterogeneity and metastasis. J Clin Oncol 1983;1:496-509.
23. Nachman J, Simon MA, Dean L, Shermeta D, Dawson P, Vegelzang N. Disparate histologic response in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol 1987;5:1185-90.